BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 30563329)

  • 1. Development and Testing of Druglike Screening Libraries.
    Wang J; Ge Y; Xie XQ
    J Chem Inf Model; 2019 Jan; 59(1):53-65. PubMed ID: 30563329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BonMOLière: Small-Sized Libraries of Readily Purchasable Compounds, Optimized to Produce Genuine Hits in Biological Screens across the Protein Space.
    Mathai N; Stork C; Kirchmair J
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case.
    Kogej T; Blomberg N; Greasley PJ; Mundt S; Vainio MJ; Schamberger J; Schmidt G; Hüser J
    Drug Discov Today; 2013 Oct; 18(19-20):1014-24. PubMed ID: 23127858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scopy: an integrated negative design python library for desirable HTS/VS database design.
    Yang ZY; Yang ZJ; Lu AP; Hou TJ; Cao DS
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32892221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High impact technologies for natural products screening.
    Koehn FE
    Prog Drug Res; 2008; 65():175, 177-210. PubMed ID: 18084916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Based Virtual Screening of Commercially Available Compound Libraries.
    Kireev D
    Methods Mol Biol; 2016; 1439():65-76. PubMed ID: 27316988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating DNA-encoded chemical libraries with virtual combinatorial library screening: Optimizing a PARP10 inhibitor.
    Lemke M; Ravenscroft H; Rueb NJ; Kireev D; Ferraris D; Franzini RM
    Bioorg Med Chem Lett; 2020 Oct; 30(19):127464. PubMed ID: 32768646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent trends and observations in the design of high-quality screening collections.
    Renner S; Popov M; Schuffenhauer A; Roth HJ; Breitenstein W; Marzinzik A; Lewis I; Krastel P; Nigsch F; Jenkins J; Jacoby E
    Future Med Chem; 2011 Apr; 3(6):751-66. PubMed ID: 21554080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docking and Virtual Screening in Drug Discovery.
    Kontoyianni M
    Methods Mol Biol; 2017; 1647():255-266. PubMed ID: 28809009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.
    Zuegg J; Cooper MA
    Curr Top Med Chem; 2012; 12(14):1500-13. PubMed ID: 22827520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening Library Design.
    Ashenden SK
    Methods Enzymol; 2018; 610():73-96. PubMed ID: 30390806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal HTS Fingerprint Definitions by Using a Desirability Function and a Genetic Algorithm.
    Cortes Cabrera A; Petrone PM
    J Chem Inf Model; 2018 Mar; 58(3):641-646. PubMed ID: 29425455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teaching an Old Dog New Tricks: Strategies That Improve Early Recognition in Similarity-Based Virtual Screening.
    Liu R; AbdulHameed MDM; Wallqvist A
    Front Chem; 2019; 7():701. PubMed ID: 31709231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Analysis of Different Components of a High-Throughput Screening Library.
    Saha A; Varghese T; Liu A; Allen SJ; Mirzadegan T; Hack MD
    J Chem Inf Model; 2018 Oct; 58(10):2057-2068. PubMed ID: 30204440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: recent trends in library design and virtual screening in medicinal chemistry and drug discovery.
    Kumar BV; Sriram D; Yogeeswari P
    Curr Top Med Chem; 2014; 14(16):1865. PubMed ID: 25262807
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
    Mahasenan KV; Li C
    J Chem Inf Model; 2012 May; 52(5):1345-55. PubMed ID: 22540736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bead-based screening in chemical biology and drug discovery.
    Komnatnyy VV; Nielsen TE; Qvortrup K
    Chem Commun (Camb); 2018 Jun; 54(50):6759-6771. PubMed ID: 29888365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating computational and mixture-based screening of combinatorial libraries.
    Yongye AB; Pinilla C; Medina-Franco JL; Giulianotti MA; Dooley CT; Appel JR; Nefzi A; Scior T; Houghten RA; Martínez-Mayorga K
    J Mol Model; 2011 Jun; 17(6):1473-82. PubMed ID: 20853183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Chemical Compound Libraries for In Silico Drug Screening.
    Fukunishi Y; Lintuluoto M
    Curr Comput Aided Drug Des; 2010; 6(2):90-102. PubMed ID: 20402662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.